MedPath

Tavilermide

Generic Name
Tavilermide
Drug Type
Small Molecule
Chemical Formula
C24H32N6O11
CAS Number
263251-78-1
Unique Ingredient Identifier
NMG938VJ6T

Overview

Tavilermide has been investigated for the treatment of Dry Eye Syndromes.

Background

Tavilermide has been investigated for the treatment of Dry Eye Syndromes.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath